Which anaesthetic agent for maintenance during normothermic cardiopulmonary bypass?

British Journal of Anaesthesia

Volumn 90, Issue 2, 2003, Pages 118-121

  Marks, R R D ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPLEGIC AGENT; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; ISOFLURANE; POTASSIUM; PROPOFOL; SODIUM CHLORIDE; THIOPENTAL;

ACID BASE BALANCE; ANESTHESIA INDUCTION; ASYSTOLE; BODY TEMPERATURE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN PROTECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; COGNITIVE DEFECT; COOLING; CORONARY ARTERY; CORRELATION ANALYSIS; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG UPTAKE; EDITORIAL; ELECTROENCEPHALOGRAPHY; HEART INFARCTION PREVENTION; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HUMAN; LUNG PERFUSION; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT OUTCOME; VAPORIZER; WARMING;

EID: 0037316304     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeg027     Document Type: Editorial

References (26)

1. Holley FO, Pongains KV, Stanski DR, et al. Effect of cardiopulmonary bypass on the pharmacokinetics of drugs. Clin Pharm 1982; 7: 234-51
2. Grigore AM, Grocott HP, Mathew JP, et al. The rewarming rate and increased peak temperature alter neurocognitive outcome after cardiac surgery. Anesth Analg 2002; 94: 4-10
3. Enomoto S, Hindman BJ, Dexter F, et al. Rapid rewarming causes an increase in the cerebral metabolic rate for oxygen that is temporarily unmatched by cerebral blood flow. A study during bypass in rabbits. Anesthesiology 1996; 84: 1392-400
4. Oxelbark S, Bengtsson L, Eggersen M. Fast track as a routine for open heart surgery. Eur J Cardiothorac Surg 2001; 19: 460-3
5. Schmidlin D, Hager P, Schmid ER. Monitoring the level of sedation with bispectral EEG analysis: comparison between hypothermic and normothermic cardiopulmonary bypass. Br J Anaesth 2001; 86: 769-76
6. Newman MF, Kirchner JL, Phillips-Bute B, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med 2001; 344: 395-402
7. Eger EI, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology 1965; 26: 756-63
8. Lockwood GG, Sapsed-Byrne SM, Adams S. A comparison of anaesthetic tensions in arterial blood and oxygenator exhaust gas during cardiopulmonary bypass. Anaesthesia 1999; 54: 434-6
9. Loomis CW, Brunet D, Milne B, et al. Arterial isoflurane concentration and EEG burst suppression during cardiopulmonary bypass. Clin Pharmacol Ther 1986; 40: 304-13
10. Newman MF, Croughwell ND, White WD, et al. Pharmacologic electroencephalographic suppression during cardiopulmonary bypass: a comparison of thiopental and isoflurane. Anesth Analg 1998; 86: 246-51
11. Nussmeier NA, Moskowitz GJ, Weiskopf RB, et al. In vitro anesthetic wash in and washout via bubble oxygenators: influence of anesthetic solubility and rates of carrier gas inflow and pump blood flow. Anesth Analg 1988; 67: 982-7
12. Hickey S, Gaylor JD, Kenny GN. In vitro uptake and elimination of isoflurane by different membrane oxygenators. J Cardiothorac Vasc Anesth 1996; 10: 352-5
13. Yoshitani K, Kawaguchi M, Masahiro T, et al. Plasma propofol concentration and EEG burst suppression ratio during normothermic cardiopulmonary bypass. Br J Anaesth 2003; 90: 122-6
14. Doyle PW, Matta BF. Burst suppression or isoelectric encephalogram for cerebral protection: evidence from metabolic suppression studies. Br J Anaesth 1999; 83: 580-4
15. Nussmeier NA, Arlund C, Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986; 64: 165-70
16. Newman MF, Murkin JM, Roach G, et al. Cerebral physiologic effects of burst suppression doses of propofol during nonpulsatile cardiopulmonary bypass. Anesth Analg 1995; 81: 452-7
17. Warner DS, Takaoka S, Wu B, et al. Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischaemia. Anesthesiology 1996; 84: 1475-84
18. Warltier DC, Kersten JR, Pagel PS, et al. Anesthetic preconditioning: serendipity and science. Anesthesiology 2002; 97: 1-3
19. + channels in cardiac muscle. Nature 1983; 305: 147-8
20. Martini N, Preckel B, Thämer V, et al. Can isoflurane mimic ischaemic preconditioning in isolated rat heart? Br J Anaesth 2001; 86: 269-71
21. ATP channels via multiple signaling pathways. Anesthesiology 2002; 97: 4-14
22. ATP channel activity and cardiomyocyte protection. Anesthesiology 2002; 97: 15-23
23. Sayin MM, Özatamer O, Taöz R, et al. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002; 89: 242-6
24. Haroun-Bizri S, Khoury SS, Chehab IR, et al. Does isoflurane optimise myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 2001; 15: 418-21
25. De Hert SG, Broecke PW, Mertens E, et al. Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 2002; 97: 42-9
26. Recommendations for standards of monitoring and alarms during cardiopulmonary bypass. Society of Perfusionists of Great Britain and Ireland, Association of Cardiothoracic Anaesthesists, Society of Cardiothoracic Surgeons of Great Britain & Ireland, 2001